On this week’s podcast we have a conversation with Jordi Mata-Fink, co-founder and chief executive officer of the newly-launched U.S. company Gate Bioscience. 00:45-01:06: About Gate Bioscience 01:06-02:09: What are disease-causing extracellular proteins? 02:09-04:44: How have diseases caused by extracellular proteins been treated in the past?  04:44-05:47: Have there been diseases that haven’t been addressed?  05:47-07:05: Tackling the different issues created by extracellular proteins  07:05-09:41: What are molecular gates?  09:41-12:56: How does your technique distinguish between good and bad extracellular proteins? 12:56-16:24: How did the idea become a company? 16:24-17:24: Which diseases will you focus on? 17:24-18;47: How do you address costs? 18:47-19:11: How will this be given to patients? 19:11-20:01: Disease cure or disease management? 20:01-21:35: How was the company created? 21:35-24:18: The rise of small molecules 24:18-25:58: What are the next steps? Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!  Stay updated by subscribing to our newsletter